It is our privilege to count amongst our partners pharmaceutical companies, public and private institutions, healthcare professionals, the scientific community and service providers. Our experienced business development team is constantly exploring the market for new opportunities and partnerships.
From an internal point of view, HRA-Pharma brings to the table experience in clinical and product development, regulatory matters (including complex regulatory Rx-to-OTC switches), marketing, and supply chain capabilities. We are adept at launching new brands on a global scale and at understanding the evolving needs of the people we serve.
Our products are marketed in more than 90 countries.
We are able to leverage our size and adapt quickly to the needs of our partners. We are agile and skilled in doing so. Our wealth of experience and flexibility when structuring deals, for example, has enabled us to maximize the value of our portfolio via in-licensing and out-licensing agreements. We currently market both proprietary and in–licensed products in France and parts of Europe, and out-license our products to marketing partners in other areas of the world.
We are able to set up joint clinical trials, co-marketing and co-promotional programs.
In less than 18 years, we have signed 2.169 agreements, including 154 product transactions and 175 research collaborations.
HRA Pharma is always open to pursuing new opportunities in order to broaden our consumer healthcare reach and meet the needs of people across the world.